Trials / Completed
CompletedNCT00301665
Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis
A Phase II, Multicentre, Randomised, Double-blind, Parallel Groups, Placebo Controlled Clinical Study of Efficacy and Safety of Dysport® for Migraine Prophylaxis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 138 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of botulinum toxin type A (Dysport®) injections into pericranial muscles compared to placebo to prevent migraine attacks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Botulinum toxin type A |
Timeline
- Start date
- 2003-02-01
- Completion
- 2005-03-01
- First posted
- 2006-03-13
- Last updated
- 2020-04-24
Locations
9 sites across 3 countries: Czechia, Poland, Slovakia
Source: ClinicalTrials.gov record NCT00301665. Inclusion in this directory is not an endorsement.